In the past 52-week period, shares of Boston Scientific Corporation (NYSE:BSX) have moved within the range of $19.67 to $29.93. On the stock’s most recent trading day, the company’s shares ended the regular session at $28.51, which is 4.74% lower than its 52-week high.
Boston Scientific Corporation (BSX) has demonstrated a 20-day simple moving average (SMA) of 1.03%, and a 50-day SMA of -1.03%. This public company’s current market capitalization stands at $39.12 billion.Analyzing Consensus Estimates, Sales Revenue and Net Income
Understanding Wall Street analyst’s enthusiasm for a particular stock is crucial when considering entering a position. According to the latest data, the consensus recommendation for Boston Scientific Corporation (BSX) is Outperform.
When it comes to sales data, public companies usually post revenue and earnings that are either higher or lower than the average Wall Street forecast. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Boston Scientific Corporation (BSX) delivered a 0.68% surprise with its net revenue. Sales reached $2.22 billion during the three-month period, compared to the average analyst estimate of $2.21 billion.
Meanwhile, during the same quarter Boston Scientific Corporation (BSX) delivered a 0.71% earnings surprise. Net earnings for the quarter were posted at $0.31 per share, whereas Wall Street had forecast $0.31 per share.Ownership at Boston Scientific Corporation (BSX), According to Most Recent SEC Filings
A public company’s latest 13F filings tell investors important details about institutional ownership. Boston Scientific Corporation (BSX) has 0 billion shares outstanding currently, 95.17% of which belong to institutional investors. Those institutional holdings amount to $37.46 billion.
Additionally, according to the most recent 13F filing from Boston Scientific Corporation (BSX), there were 37 new positions totaling 13,995,672 shares of the company’s stock. There were 44 sold out positions, on the other hand, totaling 3,047,688 shares.Short, Medium and Long Term Indicators
Examining a stock’s average volume in the short, medium and long term is useful to understand trading activity and investor sentiment. Boston Scientific Corporation (BSX) has had a 20-day average volume of 6,180,275 shares, with an average of 20% of short term indicators pointed at Sell.
The stock’s 50-day average volume has been 5,298,096 shares, with an average of 25% of medium term indicators pointing toward Buy. Finally, its 100-day average volume is 5,120,359 shares with 67% of long-term indicators pointing to Buy.